HCPCS 2013 Code Changes

Internal Medicine Print Friendly and PDF
New
Code Description
A9586 Florbetapir f18, diagnostic, per study dose, up to 10 millicuries
C9294 Injection, taliglucerase alfa, 10 units
C9295 Injection, carfilzomib, 1 mg
C9296 Injection, ziv-aflibercept, 1 mg
G0453 Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure)
G0454 Physician documentation of face-to-face visit for durable medical equipment determination performed by nurse practitioner, physician assistant or clinical nurse specialist
G0456 Negative pressure wound therapy, (e. G. Vacuum assisted drainage collection) using a mechanically-powered device, not durable medical equipment, including provision of cartridge and dressing(s), topical application(s), wound assessment, and instructions for ongoing care, per session; total wounds(s) surface area less than or equal to 50 square centimeters
G0457 Negative pressure wound therapy, (e. G. Vacuum assisted drainage collection) using a mechanically-powered device, not durable medical equipment, including provision of cartridge and dressing(s), topical application(s), wound assessment, and instructions for ongoing care, per session; total wounds(s) surface area greater than 50 square centimeters
G8926 Spirometry test not performed or documented, reason not given
G8930 Assessment of depression severity not documented, reason not given
G8931 Assessment of depression severity not documented, reason not given
G8947 One or more neuropsychiatric symptoms
G8950 Pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up documented
G8951 Pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up not documented, patient not eligible/not appropriate
G8952 Pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given
G8956 Patient receiving maintenance hemodialysis in an outpatient dialysis facility
G8957 Patient not receiving maintenance hemodialysis in an outpatient dialysis facility
G8967 Warfarin or another oral anticoagulant that is fda approved prescribed
G8969 Documentation of patient reason(s) for not prescribing warfarin or another oral anticoagulant that is fda approved (e. G. , economic, social, and/or religious impediments, noncompliance or patient refusal, other patient reasons)
G8971 Warfarin or another oral anticoagulant that is fda approved not prescribed, reason not given
G8973 Most recent hemoglobin (hgb) level < 10 g/dl
G8974 Hemoglobin level measurement not documented, reason not given
G8975 Documentation of medical reason(s) for patient having a hemoglobin level < 10 g/dl (e. G. , patients who have non-renal etiologies of anemia [e. G. , sickle cell anemia or other hemoglobinopathies, hypersplenism, primary bone marrow disease, anemia related to chemotherapy for diagnosis of malignancy, postoperative bleeding, active bloodstream or peritoneal infection], other medical reasons)
G8976 Most recent hemoglobin (hgb) level >= 10 g/dl
J0178 Injection, aflibercept, 1 mg
J0485 Injection, belatacept, 1 mg
J0716 Injection, centruroides immune f(ab)2, up to 120 milligrams
J0890 Injection, peginesatide, 0. 1 mg (for esrd on dialysis)
J1050 Injection, medroxyprogesterone acetate, 1 mg
J1741 Injection, ibuprofen, 100 mg
J1744 Injection, icatibant, 1 mg
J2212 Injection, methylnaltrexone, 0. 1 mg
J7178 Injection, human fibrinogen concentrate, 1 mg
J7315 Mitomycin, opthalmic, 0. 2 mg
J7527 Everolimus, oral, 0. 25 mg
J9002 Injection, doxorubicin hydrochloride, liposomal, doxil, 10 mg
J9019 Injection, asparaginase (erwinaze), 1,000 iu
J9042 Injection, brentuximab vedotin, 1 mg
L8605 Injectable bulking agent, dextranomer/hyaluronic acid copolymer implant, anal canal, 1 ml, includes shipping and necessary supplies
Revised
CodeDescriptor
No Revised HCPCS code for 2013
Deleted
CodeDescriptor
C9279 Injection, ibuprofen, 100 mg
C9286 Injection, belatacept, 1 mg
C9287 Injection, brentuximab vedotin, 1 mg
C9288 Injection, centruroides (scorpion) immune f(ab)2 (equine), 1 vial
C9289 Injection, asparaginase erwinia chrysanthemi, 1,000 international units (i. U. )
G8715 Hemodialysis treatment performed less than three times per week or greater than three times per week
G8716 Documentation of reason(s) for patient not having greater than or equal to 1. 2 (single-pool clearance of urea [kt] / volume [v])
G9141 Influenza a (h1n1) immunization administration (includes the physician counseling the patient/family)
G9142 Influenza a (h1n1) vaccine, any route of administration
J1051 Injection, medroxyprogesterone acetate, 50 mg
J1055 Injection, medroxyprogesterone acetate for contraceptive use, 150 mg
J1056 Injection, medroxyprogesterone acetate / estradiol cypionate, 5mg / 25mg
J1680 Injection, human fibrinogen concentrate, 100 mg
J8561 Everolimus, oral, 0. 25 mg
J9001 Injection, doxorubicin hydrochloride, all lipid formulations, 10 mg
Q2045 Injection, human fibrinogen concentrate, 1 mg
Q2046 Injection, aflibercept, 1 mg
Q2047 Injection, peginesatide, 0. 1 mg (for esrd on dialysis)
Q2048 Injection, doxorubicin hydrochloride, liposomal, doxil, 10 mg